Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Booster Vaccines Safe in Children on Immunosuppressive Drugs

Publish date:: June 24, 2019

Key clinical point: Based on retrospective data, live vaccines appear to be safe in children with rheumatic diseases on immunosuppressive therapy.

Major finding: In 234 patients with a spectrum of rheumatic diseases, there were no serious adverse events associated with live booster vaccines.

Data Source: Retrospective multicenter analysis.

Disclosures: Dr. Moshe reported no relevant financial disclosures.

Citation:

Ann Rheum Dis. 2019 Jun;78(Suppl2):178-9.

This Week's Must Reads

First Reported Case of DLBCL With End-Stage Renal Disease,

Novel Learning Model Improves Documentation in RA,

Low Rate of Primary Hyperlipidemia Screening Reported in RA Patients,

Age, gender, and race influence treatment decisions for calcaneus fracture,

Repeat LTBI Testing Best in Patients Taking Biologics With New Risk Factors,

Must Reads in Pediatrics

AAD-NPF Pediatric Psoriasis Guideline Advises on Physical and Mental Care,

Psoriasis Risk Rises With TNF Inhibitor Use in Children With Inflammatory Disorders,

Marked Increase in Psoriasis Seen With TNFi Use in Pediatric Inflammatory Diseases,

PASI-75 With Ixekizumab Approaches 90% in Pediatric Psoriasis Study,

Anakinra Treatment for Pediatric ‘Cytokine Storms’,